{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:51:28Z","timestamp":1791337888278,"version":"4.3.1"},"reference-count":73,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Alzheimer's &amp;amp; Dementia"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>INTRODUCTION<\/jats:title><jats:p>Amyloid precursor protein (APP) transgenic mice are models of Alzheimer's disease (AD) amyloidosis, not all of AD. Diffuse, compacted, and vascular deposits in APP mice mimic those found in AD cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Most interventional studies in APP mice start treatment early in the process of amyloid deposition, consistent with a prevention treatment regimen. Most clinical trials treat patients with established amyloid deposits in a therapeutic treatment regimen.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The first treatment to reduce amyloid and cognitive impairment in mice was immunotherapy. The APP mouse models not only predicted efficacy, but presaged the vascular leakage called ARIA. The recent immunotherapy clinical trials that removed amyloid and slowed cognitive decline confirms the utility of these early APP models when used in therapeutic designs.<\/jats:p><\/jats:sec><jats:sec><jats:title>DISCUSSION<\/jats:title><jats:p>New mouse models of AD pathologies will add to the research armamentarium, but the early models have accurately predicted responses to amyloid therapies in humans.<\/jats:p><\/jats:sec>","DOI":"10.1002\/alz.13566","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T20:24:19Z","timestamp":1702412659000},"page":"1459-1464","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti\u2010amyloid therapies"],"prefix":"10.1002","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1224-7476","authenticated-orcid":false,"given":"David G.","family":"Morgan","sequence":"first","affiliation":[{"name":"Department of Translational Neuroscience, and Alzheimer's Alliance College of Human Medicine Michigan State University  Grand Rapids Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce T.","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics Stark Neurosciences Research Institute  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_2_4_3_1","first-page":"885","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner GG","year":"1984","journal-title":"BiochemBiophysResCommun"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.12.4245"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab092"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3810169"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.12.4190"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2949367"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(96)00001-2"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/373523a0"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5284.99"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13287"},{"key":"e_1_2_4_14_1","first-page":"1535","article-title":"Altered metabolism of familial Alzheimer's disease\u2010linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice","volume":"6","author":"Lamb BT","year":"1997","journal-title":"HumMolGenet"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/383710a0"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80974-5"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0198-097"},{"key":"e_1_2_4_18_1","first-page":"695","article-title":"Amyloid production and deposition in mutant amyloid precursor protein and presenilin\u20101 yeast artificial chromosome transgenic mice","volume":"2","author":"Lamb BA","year":"1999","journal-title":"NatNeurosci"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.1247"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100710200"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(01)00330-X"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1202-06.2006"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00434-3"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1662-x"},{"key":"e_1_2_4_26_1","first-page":"22","article-title":"Alzheimer's disease animal models: elucidation of biomarkers and therapeutic approaches for cognitive impairment","author":"Nakai T","year":"2021","journal-title":"Int J Mol Sci"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.24272\/j.issn.2095-8137.2022.289"},{"key":"e_1_2_4_28_1","article-title":"Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective","volume":"3","author":"Ferrer I","year":"2022","journal-title":"Free Neuropathol"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2001.7754"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0532-1"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90458-8"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.12.1791"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802395-2.00023-7"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/22124"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/35050110"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/35050116"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06943.x"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02315.x"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1078259"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-1-24"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0719-5"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.10.029"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63296-8"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.05.2351"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00649-w"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03489-0"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69113-7"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt269"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120861"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt90"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.07.001"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24188"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2010.05.004"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2884-10.2010"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-167213"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205012666141218125042"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00393-5"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12317"},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809316"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0033-8"},{"key":"e_1_2_4_61_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170056"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.27868"},{"key":"e_1_2_4_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00545-1"},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1405-14.2014"},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105365"},{"key":"e_1_2_4_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_2_4_67_1","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein S","year":"2022","journal-title":"JPAD"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn261"},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25380"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X211035625"},{"key":"e_1_2_4_72_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355517"},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013211"},{"key":"e_1_2_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.09.014"}],"container-title":["Alzheimer's &amp; Dementia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.13566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:57:05Z","timestamp":1759946225000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.13566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1002\/alz.13566"],"URL":"https:\/\/doi.org\/10.1002\/alz.13566","archive":["Portico"],"relation":{},"ISSN":["1552-5260","1552-5279"],"issn-type":[{"value":"1552-5260","type":"print"},{"value":"1552-5279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"2023-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}